Ja
Jamjoom Pharma
Jeddah SAFounded 19922,000 employees
Private CappharmaPrivateOphthalmologyDermatology
Platform: Ophtho Derm
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Elranaritide | JAM-9515 | NDA/BLA | 1 | CD38 | IPF | ||
| JAM-9461 | JAM-9461 | Phase 2/3 | 1 | AuroraA | NarcolepsyBCC | ||
| JAM-4301 | JAM-4301 | Phase 1/2 | 2 | VEGF | Narcolepsy |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)